Psilocybin performed about as well as the SSRI escitalopram as a treatment for moderate-to-severe major depressive disorder, according to a new double-blinded, randomized experiment.
Each year, nearly a million children develop TB and 205,000 die of TB-related causes. More than 80% of childhood TB deaths occur in those under the age of 5.
In a recently study published in Nature Communications, researchers from France’s Institut Pasteur describe several successful preclinical tests of this asthma vaccine in mice.
The development, made by a team at Harvard University’s School of Engineering and Applied Science, increases the lifetime of electric vehicles while simultaneously increasing their range and reducing their charge time.
The new study conducted by researchers at Johns Hopkins University analyzed historical blood samples of more than 4,800 middle-aged and elderly subjects collected around a decade ago.
The extremely promising data are the first Phase 3 results to be revealed for any psychedelic-based therapy, paving the way for a landmark US Food and Drug Administration (FDA) approval in 2023.
Engineers at Duke University have developed the world’s first fully recyclable printed electronics, demonstrated in the form of a transistor that can be reduced to its original building blocks with the help of baths and sound waves.
Scientists at Berkeley Lab and UC Berkeley discovered that water or soil composts converted the enzyme-embedded plastic into its building blocks and eliminated microplastics in a few weeks.
Scientists from the University of Oxford have developed a vaccine that they say gives “unprecedented” protection against malaria, a deadly mosquito-borne disease that killed more than 400,000 people worldwide last year.
Reflective white paints currently on the market only reflect 80-90% of sunlight and absorb ultraviolet light. The researchers’ paint can successfully cool buildings, as it reflects 98% of sunlight.
